The current earnings forecast score of Scholar Rock Holding Corp is 8.78, ranking 59 out of 385 in the Biotechnology & Medical Research industry. The average price target is 47.50, with a high of 53.00 and a low of 42.00.
Analyst Rating
Based on
18
analysts
Buy
Current Rating
59.533
Target Price
+21.35%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
Scholar Rock Holding Corp
SRRK
18
Beigene Ltd
ONC
28
Ionis Pharmaceuticals Inc
IONS
26
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
25
Insmed Inc
INSM
23
1
2
3
...
99
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Scholar Rock Holding Corp's expected revenue for the next quarter?
Scholar Rock Holding Corp's expected revenue is 50.00K.
What is Scholar Rock Holding Corp's price target?
Analysts forecast that Scholar Rock Holding Corp's price target is USD 47.50, with the highest forecast at USD 53.00 and the lowest forecast at USD 42.00.
How have Scholar Rock Holding CorpSRRK's recent earnings per share performed?
The market expectation was USD -0.82, while Scholar Rock Holding CorpSRRK's earnings per share (EPS) for the previous quarter was USD -0.75. EPS for the next quarter is expected at USD -0.84.
What is the analyst rating for Scholar Rock Holding Corp?
Based on the ratings of Scholar Rock Holding Corp's stock from 18 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.